Rousselot announces the latest results of published study on the effects of Peptan® collagen peptides on bone remodelling

摘要

Rousselot, a Darling Ingredient global brand and a leading global manufacturer of gelatin and collagen peptides, has revealed the findings of a study investigating the effects of Peptan collagen peptides on bone metabolism1. Using a pioneering clinical screening approach developed by the French National Institute for Agronomic Research (INRA) as part of the collaboration, the study set off to investigate the cellular mechanisms behind the overall benefits of collagen peptides on bone health. Published in the peer-reviewed journal Nutrients, the results indicated that Peptan collagen peptides directly target and modulate the function of bone-remodelling cells, providing further evidence that the benefits of bioactive collagen peptides go beyond simple protein supplementation and are an effective nutritional intervention to support bone health.